COMMUNIQUÉS West-GlobeNewswire
-
Probiodrug announces encouraging results of the Phase 2a SAPHIR Study
11/06/2017 - 21:06 -
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia
11/06/2017 - 17:01 -
Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie
11/06/2017 - 17:01 -
New analysis shows Soliqua® 100/33 lowered HbA1c by more than 2% in patients with screening levels greater than 9%
10/06/2017 - 19:14 -
Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia
10/06/2017 - 19:08 -
XBiotech Announces Discontinuation of Phase III Study for Colorectal Cancer Based on Second Interim Analysis
09/06/2017 - 21:10 -
Medable Launches Synapse, a Fully Integrated Clinical Care App Platform Using CareKit
09/06/2017 - 19:10 -
Medable lance Synapse, une plateforme d'application de soins cliniques intégralement intégrée utilisant CareKit
09/06/2017 - 19:10 -
Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
09/06/2017 - 17:45 -
Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017
09/06/2017 - 17:38 -
Targovax ASA: Notice of Extraordinary General Meeting
09/06/2017 - 15:41 -
Sixth Annual HOOPP LEAP Awards Honours Property Managers and Tenants for Outstanding Performance, Collaboration and Innovation
09/06/2017 - 14:00 -
La sixième cérémonie annuelle de remise des prix HOOPP LEAP honore les gestionnaires immobiliers et les locataires pour un rendement, une collaboration et une innovation exceptionnels
09/06/2017 - 14:00 -
Targovax ASA - Information on the subsequent offering - Key date information
09/06/2017 - 07:52 -
Mithra Pharmaceuticals: MITHRA RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY
09/06/2017 - 07:30 -
KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
09/06/2017 - 06:58 -
NICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE
09/06/2017 - 01:05 -
Communiqué rectificatif: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597.897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approb...
09/06/2017 - 00:05 -
TARGOVAX ASA - SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
08/06/2017 - 22:30
Pages
- « premier
- ‹ précédent
- …
- 2957
- 2958
- 2959
- 2960
- 2961
- 2962
- 2963
- 2964
- 2965
- …
- suivant ›
- dernier »